Government Contracts Law360 provides breaking news and analysis on government contracts. Coverage includes bid solicitations and major awards, bid disputes, and whistleblower suits, as well as policy developments related to international, federal, state, and municipal contracts.

Sign up for a 7-day FREE trial today!

Latest News in Government Contracts

• February 04, 2026

  NY, NJ Sue Feds Over Hudson River Tunnel Funding Pause

  New York and New Jersey have accused the U.S. Department of Transportation of unlawfully withholding $15 billion to fund the rehabilitation of aging commuter train tunnels under the Hudson River, saying the government did not give a valid reason for the decision.

• February 04, 2026

  Fed. Circ. Leans Toward Vacating $12.7M Copyright Award

  The Federal Circuit appeared likely to vacate a $12.7 million copyright infringement award against the federal government on Wednesday, pressing attorneys for a software developer and the government to answer what instructions should be given to the claims court on remand.

• February 04, 2026

  Wash. Tribes Sue Feds Over $240M Of Salmon Hatchery Funds

  Two tribes in Washington state have sued the National Oceanic and Atmospheric Administration and other federal agencies on claims the government unfairly told them they weren't eligible to apply for $240 million of Pacific salmon hatchery funds under the Inflation Reduction Act.

• February 04, 2026

  Fed. Circ. Backs Infringement Immunity For NASA Contractor

  The Federal Circuit on Wednesday endorsed a California federal judge's decision that a NASA contractor doesn't have to face a patent infringement suit from a pair of California men, given that its allegedly infringing use was authorized by the federal government.

• February 04, 2026

  New Biotech Nat'l Security Controls May Have Blunted Impact

  While the newly enacted federal prohibition against contracting with certain biotechnology providers associated with countries of concern may have consequences on U.S. companies' ability to develop drugs, the restrictions may prove to be less problematic for the industry than the significant publicity around their passage would suggest, say attorneys at Wilson Sonsini.

See more Government Contracts news